• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年皮肤黑色素瘤的基因组分析与临床管理。

Genomic analysis and clinical management of adolescent cutaneous melanoma.

机构信息

Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.

Department of Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK.

出版信息

Pigment Cell Melanoma Res. 2017 May;30(3):307-316. doi: 10.1111/pcmr.12574. Epub 2017 Apr 19.

DOI:10.1111/pcmr.12574
PMID:28097802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5435926/
Abstract

Melanoma in young children is rare; however, its incidence in adolescents and young adults is rising. We describe the clinical course of a 15-year-old female diagnosed with AJCC stage IB non-ulcerated primary melanoma, who died from metastatic disease 4 years after diagnosis despite three lines of modern systemic therapy. We also present the complete genomic profile of her tumour and compare this to a further series of 13 adolescent melanomas and 275 adult cutaneous melanomas. A somatic BRAF mutation and a high mutational load equivalent to that found in adult melanoma and composed primarily of C>T mutations were observed. A germline genomic analysis alongside a series of 23 children and adolescents with melanoma revealed no mutations in known germline melanoma-predisposing genes. Adolescent melanomas appear to have genomes that are as complex as those arising in adulthood and their clinical course can, as with adults, be unpredictable.

摘要

儿童期黑色素瘤很少见;然而,青少年和年轻人的发病率正在上升。我们描述了一位 15 岁女性的临床病程,她被诊断为 AJCC 分期 IB 期非溃疡性原发性黑色素瘤,尽管接受了三线现代全身治疗,但在诊断后 4 年内死于转移性疾病。我们还介绍了她肿瘤的完整基因组图谱,并将其与另外 13 例青少年黑色素瘤和 275 例成人皮肤黑色素瘤进行了比较。观察到一个体细胞 BRAF 突变和一个高突变负荷,与成人黑色素瘤中的突变负荷相当,主要由 C>T 突变组成。与一系列 23 名患有黑色素瘤的儿童和青少年一起进行的种系基因组分析未发现已知种系黑色素瘤易感基因的突变。青少年黑色素瘤的基因组似乎与成年人的一样复杂,其临床病程也可能像成年人一样不可预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab7/5435926/5504d32cf6b3/PCMR-30-307-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab7/5435926/f9b809c9c320/PCMR-30-307-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab7/5435926/317058d93d44/PCMR-30-307-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab7/5435926/5504d32cf6b3/PCMR-30-307-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab7/5435926/f9b809c9c320/PCMR-30-307-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab7/5435926/317058d93d44/PCMR-30-307-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab7/5435926/5504d32cf6b3/PCMR-30-307-g003.jpg

相似文献

1
Genomic analysis and clinical management of adolescent cutaneous melanoma.青少年皮肤黑色素瘤的基因组分析与临床管理。
Pigment Cell Melanoma Res. 2017 May;30(3):307-316. doi: 10.1111/pcmr.12574. Epub 2017 Apr 19.
2
Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.对青少年和年轻成年人黑色素瘤的全基因组测序揭示了不同的突变景观,以及种系变异在疾病易感性中的潜在作用。
Int J Cancer. 2019 Mar 1;144(5):1049-1060. doi: 10.1002/ijc.31791. Epub 2018 Nov 21.
3
BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs.BRAF和NRAS突变在源自不同内脏器官的黑色素瘤中并不常见。
J Clin Pathol. 2005 Jun;58(6):640-4. doi: 10.1136/jcp.2004.022509.
4
Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.通过 array 比较基因组杂交揭示 BRAF 和 NRAS 突变原发性黑色素瘤之间明显的遗传差异。
Melanoma Res. 2012 Jun;22(3):202-14. doi: 10.1097/CMR.0b013e328352dbc8.
5
Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma.原发性皮肤黑色素瘤的临床病理特征及突变分析
Am J Dermatopathol. 2015 May;37(5):389-97. doi: 10.1097/DAD.0000000000000241.
6
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.NRAS 和 BRAF 基因突变状态与高危原发性黑色素瘤患者的黑色素瘤特异性生存之间的关联。
JAMA Oncol. 2015 Jun;1(3):359-68. doi: 10.1001/jamaoncol.2015.0493.
7
Association between dermoscopic and reflectance confocal microscopy features of cutaneous melanoma with BRAF mutational status.皮肤黑色素瘤的皮肤镜和反射式共聚焦显微镜特征与BRAF突变状态之间的关联。
J Eur Acad Dermatol Venereol. 2017 Apr;31(4):643-649. doi: 10.1111/jdv.14028. Epub 2016 Nov 14.
8
POLE mutations in families predisposed to cutaneous melanoma.易患皮肤黑色素瘤家族中的POLE基因突变。
Fam Cancer. 2015 Dec;14(4):621-8. doi: 10.1007/s10689-015-9826-8.
9
Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.部分肢端和皮肤黑色素瘤中意外的紫外线辐射(UVR)和非紫外线辐射突变负担
Lab Invest. 2017 Feb;97(2):130-145. doi: 10.1038/labinvest.2016.143. Epub 2017 Jan 9.
10
NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors.NF1 突变型黑色素瘤根据肿瘤起源呈现出不同的临床特征,并对免疫检查点抑制剂有良好的反应。
Eur J Cancer. 2021 Dec;159:113-124. doi: 10.1016/j.ejca.2021.09.035. Epub 2021 Nov 4.

引用本文的文献

1
Immune checkpoint inhibitors in pediatric patients with melanoma: a systematic literature review.黑色素瘤儿科患者中的免疫检查点抑制剂:一项系统文献综述。
Melanoma Manag. 2024 Dec;11(1):2382075. doi: 10.1080/20450885.2024.2382075. Epub 2024 Aug 26.
2
Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention.幕后揭秘:MC1R 在皮肤癌风险与预防中的作用。
Genes (Basel). 2021 Jul 19;12(7):1093. doi: 10.3390/genes12071093.
3
The Emerging Role of Ras Pathway Signaling in Pediatric Cancer.Ras 通路信号在儿科癌症中的新兴作用。

本文引用的文献

1
Analysis of protein-coding genetic variation in 60,706 humans.对60706名人类的蛋白质编码基因变异进行分析。
Nature. 2016 Aug 18;536(7616):285-91. doi: 10.1038/nature19057.
2
Pediatric and Adolescent Melanoma: A National Cancer Data Base Update.儿科和青少年黑色素瘤:国家癌症数据库更新
Ann Surg Oncol. 2016 Nov;23(12):4058-4066. doi: 10.1245/s10434-016-5349-2. Epub 2016 Jun 30.
3
Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors.选择性抗BRAF治疗期间皮肤毒性的发生:与MEK抑制剂联合使用的预防作用
Cancer Res. 2020 Dec 1;80(23):5155-5163. doi: 10.1158/0008-5472.CAN-20-0916. Epub 2020 Sep 9.
4
Targeting RAS in pediatric cancer: is it becoming a reality?靶向儿科癌症中的 RAS:这是否成为现实?
Curr Opin Pediatr. 2020 Feb;32(1):48-56. doi: 10.1097/MOP.0000000000000856.
5
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.MC1R 变异与儿童和青少年黑色素瘤:一项多中心队列回顾性汇总分析。
Lancet Child Adolesc Health. 2019 May;3(5):332-342. doi: 10.1016/S2352-4642(19)30005-7. Epub 2019 Mar 12.
6
TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness.肿瘤坏死因子-α和金属蛋白酶在黑色素瘤细胞侵袭性中的关键作用。
J Exp Clin Cancer Res. 2018 Dec 28;37(1):326. doi: 10.1186/s13046-018-0982-1.
7
Pediatric melanoma in melanoma-prone families.黑色素瘤易患家族中的小儿黑色素瘤。
Cancer. 2018 Sep 15;124(18):3715-3723. doi: 10.1002/cncr.31641. Epub 2018 Sep 12.
8
Clinical and dermoscopic characterization of pediatric and adolescent melanomas: Multicenter study of 52 cases.儿科和青少年黑色素瘤的临床和皮肤镜特征:52 例多中心研究。
J Am Acad Dermatol. 2018 Feb;78(2):278-288. doi: 10.1016/j.jaad.2017.09.065. Epub 2017 Oct 9.
Acta Derm Venereol. 2017 Feb 8;97(2):258-260. doi: 10.2340/00015555-2488.
4
The Ensembl Variant Effect Predictor.Ensembl变异效应预测器。
Genome Biol. 2016 Jun 6;17(1):122. doi: 10.1186/s13059-016-0974-4.
5
Varying proliferative and clonogenic potential in NRAS-mutated congenital melanocytic nevi according to size.根据大小,NRAS 突变的先天性黑素细胞痣具有不同的增殖和克隆形成潜力。
Exp Dermatol. 2016 Oct;25(10):789-96. doi: 10.1111/exd.13073.
6
Paediatric melanoma.小儿黑色素瘤
Pathology. 2016 Feb;48(2):155-65. doi: 10.1016/j.pathol.2015.12.001. Epub 2016 Jan 16.
7
BCFtools/RoH: a hidden Markov model approach for detecting autozygosity from next-generation sequencing data.BCFtools/RoH:一种用于从新一代测序数据中检测纯合性的隐马尔可夫模型方法。
Bioinformatics. 2016 Jun 1;32(11):1749-51. doi: 10.1093/bioinformatics/btw044. Epub 2016 Jan 30.
8
A global reference for human genetic variation.人类遗传变异的全球参考。
Nature. 2015 Oct 1;526(7571):68-74. doi: 10.1038/nature15393.
9
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.转移性黑色素瘤中对CTLA-4阻断反应的基因组关联
Science. 2015 Oct 9;350(6257):207-211. doi: 10.1126/science.aad0095. Epub 2015 Sep 10.
10
Genomic Classification of Cutaneous Melanoma.皮肤黑色素瘤的基因组分类
Cell. 2015 Jun 18;161(7):1681-96. doi: 10.1016/j.cell.2015.05.044.